Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Alembic Pharmaceuticals

Alembic Pharmaceuticals

BSE: 533573|NSE: APLLTD|ISIN: INE901L01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 22, 16:00
544.95
-1.55 (-0.28%)
VOLUME 2,831
LIVE
NSE
Nov 22, 15:50
545.40
-2.4 (-0.44%)
VOLUME 97,118
News on Alembic Pharmaceuticals
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Alembic Pharma gets USFDA nod for generic chronic iron overload treatment tablets

2.18 pm | 22 Nov 2019 |  Source: PTI

The company has received final approvals from the United States Food and Drug Administration (USFDA) for its Deferasirox tablets in the strengths of 9...

Alembic Pharma rises 2% on USFDA approval for Desonide Ointment

10.37 am | 24 Oct 2019 |  Source: Moneycontrol.com

Desonide Ointment has an estimated market size of USD 13 million for 12 months ending December 2018, according to IQVIA....

Hold Alembic Pharma; target of Rs 540: ICICI Direct

4.18 pm | 31 Jul 2019 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 540 in its research report dated July 30, 2019....

Alembic Pharma Consolidated June 2019 Net Sales at Rs 948.91 crore, up 10.01% Y-o-Y

5.45 pm | 29 Jul 2019 |  Source: Moneycontrol.com

NULL...

Alembic Pharma Standalone June 2019 Net Sales at Rs 896.74 crore, up 10.51% Y-o-Y

4.48 pm | 29 Jul 2019 |  Source: Moneycontrol.com

NULL...

1 2
Quick Links for Alembic Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.